XML 40 R30.htm IDEA: XBRL DOCUMENT v3.25.3
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Anti-dilutive stock awards were as follows for the periods presented:
Quarter Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2025202420252024
Stock awards— 333 79 334 
Total— 333 79 334 
Basic And Diluted Earnings Per Share
The following table presents the earnings per share calculation for the periods presented:
 Quarter Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
Net Income (in millions)
$908.0 $912.8 $2,889.3 $2,651.2 
Less: preferred stock dividends(5.7)(5.3)(17.2)(15.8)
Less: undistributed earnings allocated to preferred stock(5.7)(6.2)(19.1)(17.6)
Net Income Attributable to Common Shareholders of CME Group$896.6 $901.3 $2,853.0 $2,617.8 
Weighted Average Number of Common Shares (in thousands):
Basic359,686 359,400 359,653 359,329 
Effect of restricted stock and performance shares736 589 677 570 
Diluted360,422 359,989 360,330 359,899 
Earnings per Common Share Attributable to Common Shareholders of CME Group:
Basic$2.49 $2.51 $7.93 $7.29 
Diluted2.49 2.50 7.92 7.27